Zejing pharmaceutical: an advance loss of 372 million yuan to 455 million yuan in 2021

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

Chinese tech giant Huawei and Vietnam’s SHB Bank enter strategic partnership to accelerate penetration into SE Asia's financial cloud market

On April 22, Saigon-Hanoi Commercial Joint Stock Bank (SHB) of Vietnam officially announced the signing of a strategic cooperation agreement with Chinese tech giant Huawei. Under the agreement, Huawei will be deeply involved in SHB’s technical architecture design, assisting in the construction of its core data platform and providing comprehensive operational stability and security assurance.

Exclusive Interview: NAVEE GOLF Is Building a Smart Golf Ecosystem, Starting with Push Carts

In an interview with EqualOcean, Wentao Shi, Head of NAVEE GOLF, discussed the company's strategic rationale for entering the golf industry, explained how it adapted its mobility and robotics technologies for golf courses, and elaborated on why user insights had become the key differentiator in global markets.

From 0 to 2.6 million units, Ecovacs Window Robot makes "first choice" the only answer.

Deeply cultivated for 15 years, market share is the proof of trust!

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab

The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.